Aerie Pharmaceuticals, Inc. (AERI) Social Stream



Aerie Pharmaceuticals, Inc. (AERI): $15.11

-0.01 (-0.07%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AERIE PHARMACEUTICALS INC (AERI) Price Targets From Analysts

Use the tables below to see what analysts covering AERIE PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 10 $30 $9 $24.555 $15.14 62.19%
2022-01-13 9 $30 $9 $24.125 $15.14 59.35%
2022-01-27 9 $30 $9 $23.375 $15.14 54.39%
2022-02-25 9 $30 $9 $22.75 $15.14 50.26%
2022-02-28 9 $30 $7 $21.875 $15.14 44.48%
2022-05-06 9 $30 $7 $21.375 $15.14 41.18%
2022-05-09 9 $30 $6 $21.25 $15.14 40.36%
2022-05-23 9 $30 $6 $20.625 $15.14 36.23%
2022-08-08 9 $30 $6 $20.375 $15.14 34.58%
2022-08-13 8 $30 $6 $20.375 $15.14 34.58%
2022-08-19 9 $30 $6 $20.5 $15.14 35.4%
2022-08-23 8 $25 $6 $16.642 $15.14 9.92%
2022-08-24 8 $25 $6 $16.285 $15.14 7.56%
2022-08-29 9 $25 $6 $16.156 $15.14 6.71%

The Trend in the Analyst Price Target


AERI's average price target has moved down $11.11 over the prior 13 months.

Over the past 42 weeks, AERI's average upside potential has been 145.62%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 10 30 9 24.555 12.72 93.04%
2022-02-03 9 30 9 22.750 6.76 236.54%
2022-02-28 9 30 7 21.875 8.30 163.55%
2022-05-02 9 30 7 21.375 7.50 185%
2022-08-02 9 30 6 20.375 6.38 219.36%

AERI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.89 1 0 7 0 0 9

The Trend in the Broker Recommendations


AERI's average broker recommendation rating worsened by 0.45 over the prior 122 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AERI as an investment opportunity.

  • In the context of all US stocks, AERIE PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1332.19% of them.
  • AERIE PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 257.73% of Pharmaceutical Products stocks.
  • In the context of stocks in the mid market cap category, AERIE PHARMACEUTICALS INC's average analyst price target is greater than 401.07% of them.
  • In the context of Pharmaceutical Products stocks, AERIE PHARMACEUTICALS INC's number of analysts covering the stock is greater than 1181.87% of them.

In the Pharmaceutical Products industry, ABCM, USNA, and SNDL are the three stocks most similar to AERIE PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is AERI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.792 seconds.